---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-056191"
form_type: "8-K"
ticker: "RAPH"
cik: "0001415397"
company_name: "Raphael Pharmaceutical Inc."
filed_at: "2024-06-26T23:59:59+00:00"
generated_at: "2026-06-01T01:24:56.286689+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Raphael Pharmaceutical increases authorized common shares to 50M (from 21M)

## Summary
- Authorized common shares increased from 21,020,560 to 50,000,000 effective June 26, 2024.
- Board approved the increase on May 9, 2024; majority shareholders approved on May 22, 2024.
- Company filed Amended and Restated Articles of Incorporation with Nevada Secretary of State.

## SEC filing metadata
- accession: 0001213900-24-056191
- form_type: 8-K
- ticker: RAPH
- cik: 0001415397
- company_name: Raphael Pharmaceutical Inc.
- filed_at: 2024-06-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1415397/000121390024056191/0001213900-24-056191-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1415397/000121390024056191/ea0208572-8k_raphael.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-056191
- JSON: https://secwatch.observer/filing/0001213900-24-056191.json
- Plain text: https://secwatch.observer/filing/0001213900-24-056191.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.